多参数超声在肝肿瘤患者术前肝实质评估中的作用
前瞻性纳入280例肝肿瘤患者,术前用剪切波弹性成像(SWE)、剪切波频散(SWD)和衰减成像(ATI)评估肝实质,以病理为参考。ATI预测肝脂肪变分级AUC高(≥S1 0.910、≥S2 0.927、=S3 0.962);SWE预测纤维化分期优于SWD;SWD在炎症活动度评估上不优于SWE。
要点
- ATI预测肝脂肪变分级AUC为≥S1 0.910、≥S2 0.927、=S3 0.962。
- SWE预测纤维化分期AUC为≥S1 0.923、≥S2 0.934、≥S3 0.930、=S4 0.895。
- SWD在炎症活动度评估上不优于SWE。
核心结论
- 对肝肿瘤患者,ATI检测和分级肝脂肪变可行且诊断性能优良,SWE检测纤维化分期比SWD更准确,SWD检测炎症活动度不优于SWE。
研究设计与样本
- 前瞻性研究,纳入280例肝肿瘤患者,术前均行SWE、SWD和ATI检查,以组织病理学确定的纤维化分期、坏死性炎症活动度和肝脂肪变分级为参考标准。
诊断标准与关键数值
- ATI预测肝脂肪变分级的AUROC为≥S1 0.910、≥S2 0.927、=S3 0.962。
- SWE预测纤维化分期的AUROC为≥S1 0.923、≥S2 0.934、≥S3 0.930、=S4 0.895。
- SWD预测纤维化分期的AUROC为≥S1 0.858、≥S2 0.886、≥S3 0.866(原文此处写作≥S1)、=S4 0.825。
- SWE预测炎症活动度的AUROC为≥G1 0.846、≥G2 0.724、≥G3 0.787。
- SWD预测炎症活动度的AUROC为≥G1 0.777、≥G2 0.727、≥G3 0.803。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to evaluate the diagnostic performance of shear wave elastography (SWE), shear wave dispersion (SWD), and attenuation imaging (ATI) in assessment of hepatic parenchyma in patients with liver tumors before resection.
METHODS: Patients with liver tumors were prospectively enrolled in this study. All participants underwent SWE, SWD, and ATI examinations. Fibrosis stage, necroinflammatory activity and hepatic steatosis grade were determined histopathologically. We evaluated the stability of ATI, SWE and SWD examinations. Multivariable linear regression analyses were conducted to determine the determinant factors for SWE, SWD, attenuation coefficient (AC) values. A receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic performance of multiparametric US (ultrasond).
RESULTS: A total of 280 participants were enrolled in this study. TG (triglyceride) and steatosis for AC value were significant determinant factors. PLT (platelet), PT (prothrombin time), GGT (glutamyl transpeptidase), and fibrosis stage for SWE value were significant determinant factors. PLT, fibrosis stage and inflammation activity for SWD value were significant determinant factors. AC value was correlated with hepatic steatosis. Both SWE and SWD values were correlated with fibrosis stage, inflammation activity, respectively. The area under the ROC (AUROC) curve of ATI for predicting hepatic steatosis grade were 0.910(≥ S1), 0.927(≥ S2), 0.962(= S3), respectively. The AUROC curve of SWE for predicting fibrosis stage were 0.923(≥ S1), 0.934(≥ S2), 0.930(≥ S3), 0.895(= S4), respectively. The AUROC curve of SWD for predicting fibrosis stage were 0.858(≥ S1), 0.886(≥ S2), 0.866(≥ S1) (≥ S3), 0.825(= S4). The AUROC curve of SWE for predicting inflammation activity were 0.846(≥ G1), 0.724(≥ G2), 0.787 (≥ G3), respectively. The AUROC curve of SWD for predicting inflammation activity were 0.777(≥ G1), 0.727(≥ G2), 0.803 (≥ G3), respectively.
CONCLUSIONS: For patients with liver tumors, ATI technology showed excellent feasibility and diagnostic performance for detecting and grading hepatic steatosis, SWE was more accurate in detecting fibrosis stage than SWD, SWD was not superior to SWE in detecting inflammation activity.
引用
- Wang K, Zhang J, Wang J, et al. Role of multiparametric US in the preoperative assessment of hepatic parenchyma in patients with liver tumors. Abdom Radiol (NY). 2024. PMID: 39152231. doi:10.1007/s00261-024-04386-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。